Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 4/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.52 |
| ▸ | MEN1 | O00255 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.52 |
| ▸ | TP53 | P04637 | 2/20 | 0.52 |
| ▸ | HTT | P42858 | 3/20 | 0.50 |
| ▸ | MLNR | O43193 | 1/20 | 0.47 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.47 |
| ▸ | ESR1 | P03372 | 1/20 | 0.47 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.47 |
| ▸ | PGR | P06401 | 1/20 | 0.47 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.47 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.47 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.47 |
| ▸ | HTR1A | P08908 | 1/20 | 0.47 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.47 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.47 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.47 |
| ▸ | DRD2 | P14416 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5303389 | 1.00 | DNM1 (0.53) | DNM1SMN1; SMN2MEN1KMT2AMAPK1 | |
| SCHEMBL5295241 | 1.00 | DNM1 (0.53) | DNM1SMN1; SMN2MEN1KMT2AMAPK1 | |
| SCHEMBL5300779 | 1.00 | DNM1 (0.53) | DNM1SMN1; SMN2MEN1KMT2AMAPK1 | |
| SCHEMBL5284781 | 1.00 | DNM1 (0.53) | DNM1SMN1; SMN2MEN1KMT2AMAPK1 | |
| SCHEMBL5301676 | 1.00 | DNM1 (0.53) | DNM1SMN1; SMN2MEN1KMT2AMAPK1 | |
| SCHEMBL5293019 | 1.00 | DNM1 (0.53) | DNM1SMN1; SMN2MEN1KMT2AMAPK1 | |
| SCHEMBL5302291 | 1.00 | DNM1 (0.53) | DNM1SMN1; SMN2MEN1KMT2AMAPK1 | |
| SCHEMBL5292348 | 1.00 | DNM1 (0.53) | DNM1SMN1; SMN2MEN1KMT2AMAPK1 | |
| SCHEMBL5304172 | 1.00 | DNM1 (0.53) | DNM1SMN1; SMN2MEN1KMT2AMAPK1 | |
| SCHEMBL5302856 | 1.00 | DNM1 (0.53) | DNM1SMN1; SMN2MEN1KMT2AMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160251388-A1 | SULFOXIDATION CATALYSTS AND METHODS FOR THEIR PREPARATION AND USE | INDIAN INSTITUTE OF TECHNOLOGY MADRAS (IN) | 2016-09-01 | — | — | US | disclosed |
| WO-2007006418-A1 | IONIC-LIQUID-CONTAINING PRODUCTS FOR DYEING AND/OR BRIGHTENING KERATIN FIBRES | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2007-01-18 | — | — | WO | disclosed |
| WO-2006131234-A1 | COSMETIC COMPOSITIONS COMPRISING IONIC LIQUIDS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2006-12-14 | — | — | WO | disclosed |
| US-6191192-B1 | URETHRAL CATHETERS, GLOVES | TOYO BOSEKI KABUSHIKI KAISHA (JP) | 2001-02-20 | — | — | US | disclosed |
| EP-0887373-A2 | Antibacterial polymeric moldings | Toyo Boseki Kabushiki Kaisha (JP) | 1998-12-30 | — | — | EP | disclosed |
| EP-0097551-B1 | USE OF VANADIUM, NIOBIUM AND TANTALUM PEROXIDIC COMPLEXES AS REAGENTS AND CATALYSTS IN THE HYDROXYLATION OF AROMATIC HYDROCARBONS | Institut Français du Pétrole (FR) | 1986-10-15 | — | — | EP | disclosed |
| US-4529824-A | Vanadium, niobium or tanatlum peroxidic complex | INSTITUT FRANCAIS DU PETROLE (FR) | 1985-07-16 | — | — | US | disclosed |
| EP-0097551-A1 | Use of vanadium, niobium and tantalum peroxidic complexes as reagents and catalysts in the hydroxylation of aromatic hydrocarbons | Institut Français du Pétrole (FR) | 1984-01-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160251388-A1 | SULFOXIDATION CATALYSTS AND METHODS FOR THEIR PREPARATION AND USE | SMOX, TST, STS | DNM1 2320/4885SMN1; SMN2 700/4885MEN1 4415/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.